Covid Update: AccelBio launched The Goliath Platforms, the fastest, highest-throughput SARS-CoV-2 Detection System Gobally  →

Robotic Cell-based Assays and Diagnostic Services

Custom Solutions for a Range of Biotechnology Projects
AccelBio Employs Diverse Molecular Approaches
molecular
cellular
biochemistry
RNA biology
sub-cellular imaging
high-resolution imaging

Technology

  • Single Cell Genomics

  • Superresolution imaging

  • High-Throughput Robotics

  • RNA biology

  • Gene Expression Analytics

  • Stem cells / regenerative medicine

Learn more about technology

Solutions

65 Years of Experience
We are changing the way scientists and clinicians do their work by simplifying and accelerating research projects
Explore Our solutions

Innovating High-Throughput Assays for Diagnostic Testing and Drug Discovery

SARS-CoV-2
Animal models
Stem cell models
IPSCs
Custom configurations

RAPID PATHOGEN DETECTION AND DRUG SCREENING

Superior Primary Cells for Human Disease Discovery

Neurodegeneration
Cancer Biology
Immunological disorders

Primary and Transgenic Cell providers

Including neurodegenerative disorders such as Alzheimer's, Parkinson's and Huntington's and motor neuron disease, as well as immunological disorders like AML and Hodgkins.

Cryopreserved Cells from Genetically Modified Animals

CRISPR
Cryoprotection technology
Neurons
Custom services
Immune Cells
Liver Cells

CUSTOM BIOLOGY / TRANSGENIC PROJECTS

Our team has provided superior stem cells derived from customer sources for several regenerative medicine breakthroughs.
Cellular technologies
Genetic technologies

Regenerative Medicine

We are pioneering several applications in metabolic and neurodegenerative diseases for cGMP and cGCP production of cells for transplantation and emerging gene therapy programs. This work is in collaboration with world leaders in CDMO production of cGCP material for human clinical trials. This program implements new methodologies that fosters preservation of trans-differentiated cell states after specific gene pathway induction, differentiation or transgenic applications. We are currently working with several leading biopharmaceutical corporations in this application.

Rigorous Chain of Custody for Cells and Biologics
Surgery
Regenerative medicine
Proprietary technology
Research & Discovery
Clinical Applications
Proud to collaborate
Our customers include some of the best known Pharmaceuticals, Biotech, Universities, Institutes and Laboratories in the world

What our customers say

“AccelBio swiftly executed our drug studies in animal models of disease to yield important patentable data for our discovery portfolio.”

Knut Wittkowski
CEO Asdera

“When our discovery programs require primary neurons, we always turn to AccelBio. We always get quality results that we can have a high level of confidence in.”

Christopher Rex
CSO Afraxis, Inc.
That's what we stand for
less staff time devoted to cell harvesting logistics
no more unhealthy cells, only consistently perfect cultures
substantially lower cost than in-house production
increased productivity with no lag time to experiments
superior morphology and health, yielding better scientific results
maintained cellular states for sensitive or difficult trans-differentiated cells

Industry news

Scientists warn of new coronavirus variant spreading across Europe

Genetic mutation that originated in Spain transmitted by returning holidaymakers, researchers find...

Rapid Covid-19 test used by NBA receives $481 million boost

Cue Health to increase production of 25-minute test that uses a smartphone app

How we can help you?
Tell about your specific assay needs to one of our scientists and we will get back to you within 24 hours
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.